ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 636009 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 636009; 2) Community: the network communities that were significantly associated with the response to NSC 636009; 3) Molecule: the relationships between components within communities and NSC 636009; 4) MDR: the compounds that were significantly associated with the NSC 636009.

NSC Compound Enrichment Correlation
NSC 661820 Null 0.0123744972338279 -0.22213266
NSC 671174 Null 0.0123744972338279 0.11846487
NSC 678345 1S,5S-8-(E)-Benzylidene-5-(3-hydroxyphenyl)-2-methyl-2-azabicyclo[3.3.1]nonan-7-one, perchlorate 0.0123744972338279 -0.057168415
NSC 694000 2-Butenedioic acid, (E)-, 2-[3-[[[[2-(acetyloxy)ethoxy] methyl]-3H-1,2,3-triazol-4-yl]methyl]- 1,2,3,4-tetrahydro-5-methyl-2,4-dioxo-1-pyrimidinyl]-,diethyl ester 0.0123744972338279 0.17623508
NSC 699139 Null 0.0123744972338279 -0.23860807
NSC 700913 Null 0.0123744972338279 0.17068334
NSC 710546 Null 0.0123744972338279 -0.26336573
NSC 727987 NSC 708783 incorporated in micelles, 0.20% (w/w) of drug 0.0123744972338279 -0.24780854
NSC 736606 Null 0.0123744972338279 -0.24805004
NSC 746035 2-4-[(5-2,6-dimethoxy-4-[5-(3,4,5-trimethoxyphenyl)-4,5-dihydro-3-isoxazolyl]phenoxypentyl)oxy]-3-methoxyphenyl-1,2,3,4-tetrahydro-4-quinazolinone 0.0123744972338279 0.086447911
Total:57  Current:14    [First] [Prev] [Next] [Last]